
Pharming Group N.V. PHAR
$ 8.86
-1.01%
Annual report 2023
added 02-15-2025
Country |
![]() |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Sijmen de Vries M.B.A., M.D., MBA |
Employees in the company |
258 |
Shares |
- |
Market Cap[1] |
$ 7.59 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.